You are on page 1of 97

Hemodialysis Catheter-related

infection

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 1


CAN YOU MAKE A DIFFERNCE??
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 2
OUTLINE
 Statistics.
 How to reduce infection?
 Infection types.
 CDC data.
 Ochsner data.
 Proposed protocol for dialysis infection control.

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 3


ESRD Prevalence
USRDS 2020

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 5


In Center
HD

Transplant

PD

Home HD

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 6


303

257

111

7
8
Vascular access use at initiation and on day
of eligibility, 2011.

USRD
50% S2013

Figure 1.21 (Volume 2) Incident hemodialysis patients, 2011. USRDS


2013.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 9
Access use at first outpatient hemodialysis,
by pre-ESRD nephrology care, 2011

USRD
S
2013

Figure 1.22 (Volume 2) Incident hemodialysis patients, 2011. USRDS


2013

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 10


Access use at first outpatient hemodialysis,
by pre-ESRD nephrology care, 2011

HD catheter
USRDS
2020

Figure 1.22 (Volume 2) Incident hemodialysis patients, 2011. USRDS 2013


JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 11
HD Catheters

70%

USRDS 2020
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 12
USRDS 2020
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 13
92%

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 14


We have to learn how to live with the
hemodialysis catheters, whether we like it or not.
Jafar Alsaid

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 15


How can we improve our catheter care and
reduce infection?

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 16


Hemodialysis catheter infection

 Second cause of mortality.

 First cause of Morbidity.

 Bacterial flora migration.

 Exoluminal and Endoluminal growth.

 Increased catheter loss, bacteremia, hospitalization.

Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: The
USRDS Wave 2 study. Kidney Int 68: 311–318, 2005

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 17


Catheter Bacterial Colonization
C

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 18


Types of catheters
 Cuffed / non-Cuffed.

 Gauge.

 Length.

 Luminal design.

 Material.

 Tip design.

 Antiseptic impregnated.

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 19


Catheter related Bacteremia
 Cuffed rate 1.6-5.5/1000 d.
 Non cuffed 3.8-6.6/1000 d.

High mortality and morbidity.


Related with Catheter tip colonization.

Higher risks:
 Immunosuppressed patients.
 S. Alb < 3.5g/dl.

Organisms; G+, less common G- bacilli.

Beathard GA, Urbanes A: Infection associated with tunneled hemodialysis catheters. Semin dial 21: 528–538, 2008.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 20
DURATION

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 21


Hemodialysis catheter infection
Rate of uncuffed cath. infection:
 8% by 2wks.

 25% by 1 month.

 50% by 2 months.

Catheter related septicemia is 2 -20%.

Agarwal, Anil K, Asif Arif. NephSAP. Interventional Nephrology, ASN. 361-375. 2009.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 22
Recommended duration for HD catheters:

Vascath:
 IJ 2-3wks?
 Subclavian 2-3wks?
 Femoral. 2-5days?

Cuffed tunneled:
 1 year –Indefinite.

Agarwal, Anil K, Asif Arif. NephSAP. Interventional


JAFAR ALSAID, M.B.CH.B, MD. Nephrology,
FASN. FACP. 2021 ASN. 361-375. 2009. 23
Cuffed Tunneled Cath. Duration
Catheter survival will depend on:
1. Design.

2. Site of insertion.

3. Rt. IJ > Lt IJ> Femoral.

4. Non Dm.

Fry AC, Stratton J, Farrington K, Mahna K, Selvakumar S, Thompson T, Warwicker P: Factors affecting long-term survival of tunneled
haemodialysis catheters: A prospective audit of 812 tunneled catheters. Nephrol Dial Transplant 23: 275–281, 2008
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 24
Catheter
Location

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021


25
Complication in relation with location 865 patient from 14 HD centers

Wang K, et al. BMJ Open 2015;5:e007136. doi:10.1136/bmjopen-2014-007136


JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 26
Location of HD catheters

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 27


Signs and symptoms of Hemodialysis Catheter
related infection
 Immunosuppressed patients.

 Inflammatory signs:

 redness, hotness, pain, swelling, discharge.

 Fever during Hemodialysis.

The catheter is the cause of fever unless proven otherwise.

 Redness over the exit site.

 Discharge from the exit site.

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 28


Classification of Hemodialysis Catheter related infection
Types:

1. Exit site infection.

2. Tunnel Infection.

3. Blood steam infection.

4. Distant organ septic embolization and abscesses.

Agarwal, Anil K, Asif Arif. NephSAP. Interventional


JAFAR ALSAID, M.B.CH.B, MD. Nephrology,
FASN. FACP. 2021 ASN. 361-375. 2009. 29
Investigations for catheter infection
 CBC.

 Blood Culture peripheral and from catheter.

 Catheter tip Cx. ??

 Exit site discharge.

 Others: Urine, Sputum, Drains..etc.

 Radiology: CXR, US, …etc.

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 30


Vascular access infection definitions

Agarwal, Anil K, Asif


JAFARArif. NephSAP.
ALSAID, Interventional
M.B.CH.B, MD. FASN. FACP. 2021 Nephrology, ASN. 361-375. 2009. 31
Vascular access infection definitions

Agarwal, Anil K, Asif Arif. NephSAP. Interventional Nephrology, ASN. 361-375. 2009.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 32
Hemodialysis catheter infection
Rate of uncuffed cath. infection:
 8% by 2wks.

 25% by 1 month.

 50% by 2 months.

Catheter related septicemia is 2 -20%.

Agarwal, Anil K, Asif


JAFARArif. NephSAP.
ALSAID, Interventional
M.B.CH.B, MD. FASN. FACP. 2021 Nephrology, ASN. 361-375. 2009. 33
Catheter Exit Site infection & Tunnel infection

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 34


Definition of Exit Site infection

Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 35
practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-S164.
Definition of Exit Site infection
• Erythema.

• Area < 2cm.

• Purulent Discharge.

• May be associated with


Bacteremia, fever ..etc.

Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 36
practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-S164.
Exit site infection

• Erythema, discharge and tenderness.

• Obtain Cx.

• Could be treated with Local and oral AB.

• Rarely required removing the catheter.

Agarwal, Anil K, Asif Arif. NephSAP. Interventional Nephrology, ASN. 361-375. 2009.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 37
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 38
Catheter Tunnel infection
• Inflammatory signs over the tunnel.

• Purulent discharge.

• IV AB.

• Exchange of the catheter.

• Different site.

Agarwal, Anil K, Asif Arif. NephSAP. Interventional


JAFAR ALSAID, M.B.CH.B, Nephrology, ASN. 361-375. 2009
MD. FASN. FACP. 2021 39
Catheter Tunnel infection

Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical practice guideline
for vascular access: 2019JAFAR
update.
ALSAID, Am J Kidney
M.B.CH.B, MD. FASN. Dis. 2020;75(4)(suppl 2):S1-S164.
FACP. 2021 40
Catheter related Bacteremia
Clinical picture:
 Fever with chills.

 May be only during HD.

 patient with Central catheter.

 No other focus.

 Sepsis.

Dx: Blood Cx > 15CFU. From peripheral and catheter.

Treatment: AB for 2-3 wks with exchange of the catheter.


JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 41
Definition of Central Venous Catheter Blood stream infection

AJKD Vol 75 | Iss 4 | Suppl 2 | April 2020

Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical practice
guideline for vascular access:
JAFAR ALSAID, 2019 update.
M.B.CH.B, MD. FASN.Am
FACP.J2021
Kidney Dis. 2020;75(4)(suppl 2):S1-S164. 42
Definition of Central Venous Catheter Blood stream infection

CLINICAL + BLOOD (Peripheral / Catheter) + No other source

 Clinical symptoms.

 Blood Cx. from Peripheral. Or dialysis circuit.

 Catheter (Hub or tip Cx.) >15 CFU/cath. seg. or > 100 /Cath semiquantitative

 Same organism from catheter and peripheral.

 No other apparent source.

 2 hours interval.

 Ratio > 3/1 Catheter / peripheral .

 Positive Blood Cx with no other possible source.

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 43


Investigations for catheter infection
 CBC.

 Blood Culture peripheral + from catheter.


 Catheter tip Cx. / Hub culture ??

 Exit site discharge.

 Others: Urine, Sputum, Drains..etc.

 Radiology: CXR, US, CT …etc.

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 44


Proposed protocol for catheter related for Central Venous catheter related infection

Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 45
practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-
Strict Infection Control Protocol.
Can it work?

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 46


47

Nurses' catheter
care
Infection Control
Protocol
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 48
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 49
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 50
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 51
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 52
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 53
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 54
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 55
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 56
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 57
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 58
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 59
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 60
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 61
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 62
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 63
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 64
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 65
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 66
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 67
BSH Hemodialysis population,
over 112 months. Jan.
% 2004 – May. 2013

AVF 20%

Access types:
AVG 18%

Cuffed
56%
cath.

N= 147 patients.
Vascath. 6% 8741 HD

0% 20% 40% 60%


Jafar Alsaid. 2013. ASN poster
69
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021
70
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 71
Access Type per dialysis over the years
1400

AVF AVG VC PC
1200

1000

800

600

400

200

0
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
72
ASN Poster

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 74


JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 75
HD related blood stream infection progress

International Our Unit Our Unit Our Unit Out Unit


2011 2015 2017 2019
Hemodialysis Blood stream
infection rate /100 patient 0.75-4.4 0.019 0.007 0.004 0.003
month
Admission rate for HD 108 0.79 0.68 0.73 0.4
bacteremia/1000 patient year
Admission for vascular access 110 0 0 0 0
infection

76
Hemodialysis Blood steam infection at BSH
Jan. 2004 - Sep. 2019
0.025
International data 0.75-4.4
0.02 0.02
/100 patient month

0.015

0.01
0.007
0.004
0.005
0.003

0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
77
Year
Admission for Hemodialysis related blood stream infection per 1000 patient-year

0.9
0.79 International rate 108
0.8 0.73
/ 1000 patient Year

0.68
0.7
0.6
0.5
0.4 0.4
0.3
0.2
0.1
0
2011 2015 2017 2019

Years 78
Catheter Salvage in poor access
30% AB treatment could clear infection.

80% AB with exchange over guide wire.


Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M: Bacteremia associated
with tunneled dialysis catheters: Comparison of two treatment strategies. Kidney Int 57: 2151–2155,
2000

Exchange:
 72 hours post AB.
 No need for negative blood Cx.
National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice
recommendations for vascular access 2006. Am J Kidney Dis 48[Suppl 1]: S176–S322, 2006

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 79


Antibiotic Lock
 Is indicated in reinfection with same organism.

 In limited catheter sites.

 Catheter Salvage is acceptable.

Onder AM, Chandar J, Simon N, Diaz R, Nwobi O, Abitbol CL, Zilleruelo G: Comparison of tissue plasminogen activator–
antibiotic locks with heparin–antibiotic locks in children with catheter-related bacteraemia. Nephrol Dial Transplant 23:
2604–2610, 2008.

Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE: Treatment of long-term intravascular catheter-
related bacteremia with antibiotic lock: Randomized, placebo-controlled trial. J Antimicrob Chemother 55: 90–94, 2005
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 80
Antibiotic locking solutions

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 81


Types of Antibiotic Lock
 Cefazolin, Cephotaxim, Vancomycin, Tobramycin, Gentamyin.

Concentration: 5mg/ml.

mixed with Citrate, EDTA, Heparin, rtPA. .

Systemic AB with Antibiotic lock more effective for


 G. Neg.
 Less effective for Staph. Epidermidis.
 Worst for Staph aureus.

Maya ID, Carlton D, Estrada E, Allon M: Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with antibiotic lock: A
quality improvement report. Am J Kidney Dis 50: 289–295,2007
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 82
Different AB surface coating catheters

Dwyer A: Surface-treated catheters:


JAFAR A review.
ALSAID, M.B.CH.B, Semin
MD. FASN. FACP.Dial
2021 21: 542–546, 2008 83
Antibiotic Lock
RCT
 79 children.
 264 episodes of Catheter related bacteremia.
 Early or Late Antibiotic lock.
 All with systemic AB.

Results:
 Less likely to exchange with early AB lock.
 Infection recurrence within 45 days was similar.
 Infection free survival of catheter was longer for early
AB lock.
Onder AM, Chandar J, Billings AA, Simon N, Diaz R, Francoeur D, Abitbol C,
Zilleruelo G: Comparison of early versus late use of antibiotic locks in the treatment
JAFAR
of catheter-related ALSAID, M.B.CH.B,
bacteremia. ClinMD. FASN.
J Am SocFACP. 2021
Nephrol 3: 1048–1056, 2008 84
Antibiotic Lock
RCT.
 18 children.
 24 episodes of Catheter related Bacteremia.
 Randomized to Heparin or rtPA AB lock.

 No significant difference in both.

Onder AM, Chandar J, Simon N, Diaz R, Nwobi O, Abitbol CL, Zilleruelo G:


Comparison of tissue plasminogen activator–antibiotic locks with heparin–
antibiotic locks in children with catheter-related bacteraemia. Nephrol Dial
Transplant 23: 2604–2610, 2008
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 85
Hemodialysis Catheter distant infection
 Osteomyelitis.

 Endocarditis.

 Septic arthritis.

 Spinal epidural abscess.

JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 86


Historic Point

University of Berkley 1941.


Stanford University Medical School 1945.
Minnesota University Masters 1951.
Washington University 1958-1982

Belding Scribner MD.


1921-2003
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 98
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 99

You might also like